Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Collier

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
The New England Journal of Medicine|October 29, 1998
Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 TeamD V Havlir, I C Marschner, M S Hirsch, et al.
JAMA|July 13, 2001
Prevalence and predictive value of intermittent viremia with combination hiv therapyD V Havlir, R Bassett, D Levitan, et al.
AIDS (London, England)|August 16, 2001
Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppressionD V Havlir, P B Gilbert, K Bennett, et al.
International Journal of STD & AIDS|August 24, 2013
Neurocognitive impairment in HIV-infected individuals with previous syphilisC M Marra, R Deutsch, A C Collier, et al.
The Journal of Infectious Diseases|February 22, 2001
Alterations in T cell phenotype and human immunodeficiency virus type 1-specific cytotoxicity after potent antiretroviral therapyA Seth, J Markee, A Hoering, et al.
The Journal of Infectious Diseases|February 18, 1998
Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and bloodR W Coombs, C E Speck, J P Hughes, et al.
AIDS (London, England)|November 24, 1999
The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance ProgramD Brambilla, P S Reichelderfer, J W Bremer, et al.
Annals of Internal Medicine|October 15, 1993
Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infectionA C Collier, R W Coombs, M A Fischl, et al.
American Journal of Epidemiology|September 18, 1999
Risk factors for HIV-1 shedding in semenC E Speck, R W Coombs, L A Koutsky, et al.
Journal of Neuro-Aids|January 1, 1996
Neurologic Manifestations<br />of HIV Infection Without AIDS:Follow-UP of a Cohort<br />of Homosexual and Bisexual MenC M Marra, W T Longstreth, H H Handsfield, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
The New England Journal of Medicine|October 29, 1998
Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 TeamD V Havlir, I C Marschner, M S Hirsch, et al.
JAMA|July 13, 2001
Prevalence and predictive value of intermittent viremia with combination hiv therapyD V Havlir, R Bassett, D Levitan, et al.
AIDS (London, England)|August 16, 2001
Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppressionD V Havlir, P B Gilbert, K Bennett, et al.
International Journal of STD & AIDS|August 24, 2013
Neurocognitive impairment in HIV-infected individuals with previous syphilisC M Marra, R Deutsch, A C Collier, et al.
The Journal of Infectious Diseases|February 22, 2001
Alterations in T cell phenotype and human immunodeficiency virus type 1-specific cytotoxicity after potent antiretroviral therapyA Seth, J Markee, A Hoering, et al.
The Journal of Infectious Diseases|February 18, 1998
Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and bloodR W Coombs, C E Speck, J P Hughes, et al.
AIDS (London, England)|November 24, 1999
The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance ProgramD Brambilla, P S Reichelderfer, J W Bremer, et al.
Annals of Internal Medicine|October 15, 1993
Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infectionA C Collier, R W Coombs, M A Fischl, et al.
American Journal of Epidemiology|September 18, 1999
Risk factors for HIV-1 shedding in semenC E Speck, R W Coombs, L A Koutsky, et al.
Journal of Neuro-Aids|January 1, 1996
Neurologic Manifestations<br />of HIV Infection Without AIDS:Follow-UP of a Cohort<br />of Homosexual and Bisexual MenC M Marra, W T Longstreth, H H Handsfield, et al.
Pageof 14